Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Nov 15, 2004; 10(22): 3361-3364
Published online Nov 15, 2004. doi: 10.3748/wjg.v10.i22.3361
Table 1 Reduction in tumor mass and MVD after endostatin treatment (mean ± SD)
ControlEndostatinFP
Mass1.198 ± 0.1050.197 ± 0.04922.56aP = 0.0005
MVD100.143 ± 4.29031.857 ± 3.515151.62bP = 0.0001
Table 2 Expression of VEGF and VEGFR2/Flk-1 in tumor after Endostatin treatment
PositiveNegativeχ2P
Control-VEGF (1)655(1) vs (2)0.1190.730
Endostatin-VEGF (2)664
Control-Flk-1 (3)646(3) vs (4)13.745aP = 0.001
Endostatin- Flk-1 (4)4624